This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Org. Chem. 2016, 12, 2694–2718, doi:10.3762/bjoc.12.267
Graphical Abstract
Figure 1: Schematic representation of a computer-aided drug discovery (CADD) pipeline. CADD methods are broad...
Figure 2: FDA approved drugs Saquinavir and Amprenavir for the treatment of HIV infections. (a) The structure...
Figure 3: (a) The crystal structure showing the binding of Dorzolamide (orange) to carbonic anhydrase II (pur...
Figure 4: The best ligand binding site identified by SiteHound in HIV-1 protease. The ligand binding pocket i...
Figure 5: Binding mode prediction. The known inhibitor Dorzolamide is docked into Carbonic anhydrase II cryst...
Figure 6: The molecular structure of Raltegravir. Raltegravir is an FDA approved drug used in the treatment o...
Figure 7: An example alchemical thermodynamic cycle for a protein–ligand binding free energy calculation. The...
Figure 8: Schematic diagram showing the steps involved in QSAR. Known drug molecule activity and descriptor d...
Figure 9: A few drugs discovered with the help of ligand-based drug discovery tools. (a) Zolmitriptan: used a...